Myeloperoxidase catalyzes the conjugation of serotonin to thiols via free radicals and tryptamine-4,5-dione

Chemical Research in Toxicology

Volumn 25, Issue 11, 2012, Pages 2322-2332

  Kato, Yoji ^a   Peskin, Alexander V ^b   Dickerhof, Nina ^b   Harwood, D Tim ^b   Kettle, Anthony J ^b  

^a UNIVERSITY OF HYOGO   (Japan)

^b UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; AMINO ACID; FREE RADICAL; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MYELOPEROXIDASE; SEROTONIN; THIOL DERIVATIVE; TRYPTAMINE 4,5 DIONE;

ARTICLE; CATALYST; CONJUGATE; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MOLECULAR WEIGHT; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PROTEIN FUNCTION;

BIOCATALYSIS; FREE RADICALS; HUMANS; INDOLEQUINONES; OXIDATION-REDUCTION; PEROXIDASE; SEROTONIN; SULFHYDRYL COMPOUNDS; TIME FACTORS; TRYPTAMINES;

EID: 84869435168     PISSN: 0893228X     EISSN: 15205010     Source Type: Journal    
DOI: 10.1021/tx300218f     Document Type: Article

References (34)

1. Sanger, G. J. (2008) 5-Hydroxytryptamine and the gastrointestinal tract: Where next? Trends Pharmacol. Sci. 29, 465-471
2. Jonnakuty, C. and Gragnoli, C. (2008) What do we know about serotonin? J. Cell. Physiol. 217, 301-306
3. Ramage, A. G. and Villalon, C. M. (2008) 5-Hydroxytryptamine and cardiovascular regulation Trends Pharmacol. Sci. 29, 472-481
4. Cote, F., Fligny, C., Fromes, Y., Mallet, J., and Vodjdani, G. (2004) Recent advances in understanding serotonin regulation of cardiovascular function Trends Mol. Med. 10, 232-238
5. Baldus, S., Eiserich, J. P., Mani, A., Castro, L., Figueroa, M., Chumley, P., Ma, W., Tousson, A., White, C. R., Bullard, D. C., Brennan, M. L., Lusis, A. J., Moore, K. P., and Freeman, B. A. (2001) Endothelial transcytosis of myeloperoxidase confers specificity to vascular ECM proteins as targets of tyrosine nitration J. Clin. Invest. 108, 1759-1770
6. Phillipson, M. and Kubes, P. (2011) The neutrophil in vascular inflammation Nat. Med. 17, 1381-1390
7. Zarbock, A., Polanowska-Grabowska, R. K., and Ley, K. (2007) Platelet-neutrophil-interactions: Linking hemostasis and inflammation Blood Rev. 21, 99-111
8. Dunford, H. B. and Hsuanyu, Y. (1999) Kinetics of oxidation of serotonin by myeloperoxidase compounds I and II Biochem. Cell Biol. 77, 449-457
9. Ximenes, V. F., Maghzal, G. J., Turner, R., Kato, Y., Winterbourn, C. C., and Kettle, A. J. (2010) Serotonin as a physiological substrate for myeloperoxidase and its superoxide-dependent oxidation to cytotoxic tryptamine-4,5-dione Biochem. J. 425, 285-293
10. Vikenes, K., Farstad, M., and Nordrehaug, J. E. (1999) Serotonin is associated with coronary artery disease and cardiac events Circulation 100, 483-489
11. Ban, Y., Watanabe, T., Miyazaki, A., Nakano, Y., Tobe, T., Idei, T., Iguchi, T., Ban, Y., and Katagiri, T. (2007) Impact of increased plasma serotonin levels and carotid atherosclerosis on vascular dementia Atherosclerosis 195, 153-159
12. Frishman, W. H. and Grewall, P. (2000) Serotonin and the heart Ann. Med. 32, 195-209
13. Sayre, L. M., Perry, G., and Smith, M. A. (2008) Oxidative stress and neurotoxicity Chem. Res. Toxicol. 21, 172-188
14. Jiang, X. R., Wrona, M. Z., and Dryhurst, G. (1999) Tryptamine-4,5-dione, a putative endotoxic metabolite of the superoxide-mediated oxidation of serotonin, is a mitochondrial toxin: Possible implications in neurodegenerative brain disorders Chem. Res. Toxicol. 12, 429-436
15. Wrona, M. Z. and Dryhurst, G. (1998) Oxidation of serotonin by superoxide radical: Implications to neurodegenerative brain disorders Chem. Res. Toxicol. 11, 639-650
16. Salman-Tabcheh, S., Guerin, M. C., and Torreilles, J. (1996) Potential role of the peroxidase-dependent metabolism of serotonin in lowering the polymorphonuclear leukocyte bactericidal function Free Radical Res. 24, 61-68
17. Wrona, M. Z. and Dryhurst, G. (2001) A putative metabolite of serotonin, tryptamine-4,5-dione, is an irreversible inhibitor of tryptophan hydroxylase: Possible relevance to the serotonergic neurotoxicity of methamphetamine Chem. Res. Toxicol. 14, 1184-1192
18. Singh, S., Wrona, M. Z., and Dryhurst, G. (1992) Synthesis and Reactivity of the Putative Neurotoxin Tryptamine-4,5-Dione Bioorg. Chem. 20, 189-203
19. Jiang, X. R. and Dryhurst, G. (2002) Inhibition of the alpha-ketoglutarate dehydrogenase and pyruvate dehydrogenase complexes by a putative aberrant metabolite of serotonin, tryptamine-4,5-dione Chem. Res. Toxicol. 15, 1242-1247
20. Fridovich, I. (1985) Cytochrome c. In Handbook of Methods for Oxygen Radical Research (Greenwald, R. A., Ed.) pp 213-215, CRC Press, Boca Raton.
21. Peskin, A. V. and Winterbourn, C. C. (2006) Taurine chloramine is more selective than hypochlorous acid at targeting critical cysteines and inactivating creatine kinase and glyceraldehyde-3-phosphate dehydrogenase Free Radical Biol. Med. 40, 45-53
22. Paz, M. A., Fluckiger, R., Boak, A., Kagan, H. M., and Gallop, P. M. (1991) Specific detection of quinoproteins by redox-cycling staining J. Biol. Chem. 266, 689-692
23. Wrona, M. Z. and Dryhurst, G. (1987) Oxidation chemistry of 5-hydroxytryptamine. 1. Mechanism and products formed at micromolar concentrations J. Org. Chem. 52, 2817-2825
24. Jiang, X. R., Wrona, M. Z., Alguindigue, S. S., and Dryhurst, G. (2004) Reactions of the putative neurotoxin tryptamine-4,5-dione with L-cysteine and other thiols Chem. Res. Toxicol. 17, 357-369
25. Wrona, M. Z. and Dryhurst, G. (1988) Further insights into the oxidation chemistry of 5-hydroxytryptamine J. Pharm. Sci. 77, 911-917
26. van Dalen, C. J., Whitehouse, M. W., Winterbourn, C. C., and Kettle, A. J. (1997) Thiocyanate and chloride as competing substrates for myeloperoxidase Biochem. J. 327, 487-492
27. Meotti, F. C., Jameson, G. N., Turner, R., Harwood, D. T., Stockwell, S., Rees, M. D., Thomas, S. R., and Kettle, A. J. (2011) Urate as a physiological substrate for myeloperoxidase: Implications for hyperuricemia and inflammation J. Biol. Chem. 286, 12901-12911
28. 2 and chloride Biochem. J. 228, 583-592
29. Kettle, A. J., Anderson, R. F., Hampton, M. B., and Winterbourn, C. C. (2007) Reactions of superoxide with myeloperoxidase Biochemistry 46, 4888-4897
30. Wrona, M. Z. and Dryhurst, G. (1991) Interactions of 5-hydroxytryptamine with oxidative enzymes Biochem. Pharmacol. 41, 1145-1162
31. Spencer, J. P., Jenner, P., Daniel, S. E., Lees, A. J., Marsden, D. C., and Halliwell, B. (1998) Conjugates of catecholamines with cysteine and GSH in Parkinson's disease: Possible mechanisms of formation involving reactive oxygen species J. Neurochem. 71, 2112-2122
32. Halliwell, B. (2001) Role of free radicals in the neurodegenerative diseases: Therapeutic implications for antioxidant treatment Drugs Aging 18, 685-716
33. LaVoie, M. J., Ostaszewski, B. L., Weihofen, A., Schlossmacher, M. G., and Selkoe, D. J. (2005) Dopamine covalently modifies and functionally inactivates parkin Nat. Med. 11, 1214-1221
34. Green, P. S., Mendez, A. J., Jacob, J. S., Crowley, J. R., Growdon, W., Hyman, B. T., and Heinecke, J. W. (2004) Neuronal expression of myeloperoxidase is increased in Alzheimer's disease J. Neurochem. 90, 724-733